𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liver regeneration in humans is characterized by significant changes in cellular phosphorus metabolism: Assessment using proton-decoupled 31P- magnetic resonance spectroscopic imaging

✍ Scribed by Kristen L. Zakian; Jason A. Koutcher; Sandeep Malhotra; Howard Thaler; William Jarnagin; Lawrence Schwartz; Yuman Fong


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
381 KB
Volume
54
Category
Article
ISSN
0740-3194

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In the present study we applied proton‐decoupled ^31^P magnetic resonance spectroscopic imaging (MRSI) to noninvasively assess liver metabolism in patients who had undergone a partial hepatectomy (PH). Proton‐decoupled ^31^P chemical shift imaging was performed in 47 patients 2–28 days following major hepatectomy, and the results were compared with those from eight control subjects. All studies were performed on a 1.5T MR imager (General Electric, Milwaukee, WI) equipped with a stand‐alone proton decoupler. A ^31^P‐^1^H resonator pair was used for data acquisition, and ^31^P data were obtained in 34 min. Liver regeneration was characterized by increases in phosphoethanolamine (PE), and decreases in nucleoside triphosphates (NTP), glycerophosphoethanolamine (GPE), and glycerophosphocholine (GPC). These alterations were most marked 48–72 hr after hepatectomy and returned to baseline within 3 weeks. The level of PE measured by MRSI was also found to depend on the percentage of liver that was removed, while changes in levels of cellular high energy phosphates were independent of the size of liver resection. Implementation of proton‐decoupling was critical for assessing individual phosphomonoester and phosphodiester components. This study demonstrates that ^31^P MRSI can be used to assess metabolic changes in humans during liver regeneration, and may be useful for assessing derangement of the regenerative process or guiding adjuvant chemotherapies. Magn Reson Med 54:264–271, 2005. © 2005 Wiley‐Liss, Inc.